Pediatric Survivors after HCT: Long-term screening and preventive practices
Following hematopoietic cell transplantation (HCT), pediatric recipients face a high incidence of late effects, underscoring the need for long-term monitoring and early detection. 1 To optimize the long-term care for patients with malignant and non-malignant diseases, this case-based activity explores post-autologous and allogeneic HCT screening recommendations, including: risk factors associated with exposures and late effects, screening and assessment guidelines, and vaccination schedules.
Hours of Participation for Allied Health Care Professionals
The Medical College of Wisconsin designates this activity for up to 1 hours of participation for continuing education for allied health professionals.
This activity is intended for pediatric hematologists,/oncologists, pediatricians, nurses, and other health care practitioners who care for pediatric patients following HCT.
At the conclusion of this activity, I will be able to:
- Identify the most common late effects experienced by pediatric HCT recipients that require ongoing follow up and care.
- Apply appropriate screening, testing and vaccination schedules from recommended guidelines according to each patient's exposures and risk factors.
- Utilize care planning tools as part of a patient's multidisciplinary team of care providers to identify, document and communicate needs for follow-up care.
Angela Smith, M.D., M.S.
Attending Physician, University of Minnesota Children's Hospital, Pediatric Blood and Marrow Transplantation, Minneapolis, MN
Assistant Professor of Pediatrics, Hematology/ Oncology, and Blood and Marrow Transplantation, University of Minnesota
Navneet Majhail, M.D., M.S.
Director, Bone Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio
Professor of Medicine, Department of Hematology & Oncology, Cleveland Clinic Lerner College of Medicine
Scientific Director, Center for International Blood and Marrow Transplant Research (CIBMTR), Minneapolis, MN
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.